GlassScriptPhysician profile
Ian S Tucker
NPI 1538130836
$2,764.93
in general payments reported to CMS, 2019-2025
38 companies · $1,329 in 2025
The $1,329 reported for 2025 was more than what 90% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $235 · 2020: $92.03 · 2021: $41.54 · 2022: $331 · 2023: $222 · 2024: $515 · 2025: $1,329.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,065.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,065.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $517.33 | 2023-2025 | Vraylar, Qulipta |
| Novo Nordisk INC | $305.74 | 2020-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $165.17 | 2024-2025 | Airsupra, Bevespi Aerosphere |
| Organogenesis INC. | $139.14 | 2023-2024 | Puraply |
| Pfizer INC. | $136.43 | 2020-2025 | |
| Allergan, INC. | $124.36 | 2019 | |
| Kerecis Limited | $121.22 | 2022-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Surgiclose |
| Lilly USA, LLC | $116.59 | 2024-2025 | Zepbound, Mounjaro |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $103.74 | 2025 | Caplyta |
| Convatec INC. | $96.24 | 2019-2022 | |
| Exact Sciences Corporation | $86.18 | 2024-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Smith+Nephew, INC. | $73.38 | 2019-2025 | Collagenase Santyl |
| Glaxosmithkline, LLC. | $68.66 | 2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Abbott Laboratories | $61.08 | 2023-2025 | Freestyle Libre 3 |
| Amneal Pharmaceuticals LLC | $46.10 | 2025 | Unithroid |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ian Tucker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.